National Bank of Canada’s Revolution Medicines RVMD Stock Holding History

National Bank of Canada’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205M	Sell	1,096,025 -652,975	-37%	-$95.4M	0.15%	125
2026 Q1	$170M	Buy	+1,749,000	New	+$177M	0.15%	118
2023 Q4	–	Sell	-30,783	Closed	-$755K	–	2871
2023 Q3	$755K	Hold	30,783	–	–	﹤0.01%	1271
2023 Q2	$826K	Hold	30,783	–	–	﹤0.01%	1187
2023 Q1	$655K	Buy	30,783 +5,267	+21%	+$130K	﹤0.01%	1162
2022 Q4	$608K	Hold	25,516	–	–	﹤0.01%	1221
2022 Q3	$498K	Hold	25,516	–	–	﹤0.01%	1165
2022 Q2	$533K	Buy	25,516 +3,829	+18%	+$74.5K	﹤0.01%	1196
2022 Q1	$512K	Buy	+21,687	New	+$472K	﹤0.01%	1300

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

National Bank of Canada's RVMD Position: Q2 2026 in Review

National Bank of Canada reduced its Revolution Medicines (RVMD) stake by 37% in Q2 2026, selling an estimated $95.4M and leaving 1,096,025 shares worth $205M. The position accounts for 0.15% of the portfolio, ranked #125.

National Bank of Canada first reported a position in RVMD in Q1 2022 and has held it in 9 quarters since. 689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

National Bank of Canada held 1,096,025 shares of Revolution Medicines worth $205M as of Q2 2026.
National Bank of Canada sold 652,975 Revolution Medicines shares in Q2 2026, an estimated $95.4M.
Revolution Medicines made up 0.15% of National Bank of Canada's portfolio in Q2 2026, its #125 holding.
National Bank of Canada first reported a position in Revolution Medicines in Q1 2022 and has held it in 9 quarters since.
689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.